Isoxazolone based inhibitors of p38 MAP kinases

Journal of Medicinal Chemistry

Volumn 51, Issue 8, 2008, Pages 2580-2584

  Laufer, Stefan A ^a   Margutti, Simona ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 3 (PYRIDIN 4YL) 2 TOSYLISOXAZOL 5 (2H) ONE; 4 [3 (4 FLUOROPHENYL) 5 METHOXYISOXAZOL 4 YL]PYRIDINE; 5 ALKOXYISOXAZOLE; 5 ISOXAZOLONE; IMIDAZOLE; ISOXAZOLE DERIVATIVE; ISOXAZOLONE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; N ETHYL 4 (4 FLUOROPHENYL) 5 OXO 3 (PYRIDIN 4 YL)ISOXAZOLE;

ARTICLE; STRUCTURE ACTIVITY RELATION;

MAGNETIC RESONANCE SPECTROSCOPY; OXAZOLES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 43049090109     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701343f     Document Type: Article

References (22)

1. Ono, K.; Han, J. The p38 signal transduction pathway. Activation and function. Cell. Signalling 2000, 12, 1-13.
2. Lee, J. C.; Uydon, J. T.; McDonnell, P. C.; Gallagher, T. F.; Kumar, S.; Green, D.; McNulty, D.; Blumenthal, M. J.; Heyes, J. R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372, 739-746.
3. Laufer, S. A.; Zimmermann, W.; Ruff, K. J. Tetrasubstituted imidazole inhibitors of cytokine release: probing substituents in the N-1 position. J. Med. Chem. 2004, 47, 6311-6325.
4. Laufer, S. A.; Striegel, H. G.; Wagner, G. K. Imidazole inhibitors of cytokine release: probing substituents in the 2 position. J. Med. Chem. 2002, 45, 4695-1705.
5. Laufer, S.; Striegel, H.-G.; Tollmann, K.; Albrecht, W. Preparation of 2-Methylsulfanyl-3H-imidazoles and Related Compounds as Immunomodulators. 2002-10238045[10238045]. 31; DE. 20-8-2002. 2004; Merckle G.m.b.H.Chem.-Pharm. Fabrik.Germany.
6. Adams, J. L.; Boehm, J. C.; Kassis, S.; Goryeki, P. D.; Webb, E. F.; Hall, R.; Sorenson, M.; Lee, J. C.; Ayrton, A.; Griswold, D. E.; Gallagher, T. F. Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes. Bioorg. Med. Chem. Lett. 1998, 8, 3111-3116.
7. Laufer, S. A.; Margutti, S.; Fritz, M. D. Substituted isoxazoles as potent inhibitors of p38 MAP kinase. ChemMedChem 2006, 1, 197-207.
8. Clark, M. P.; Djung, J. F.-J.; Laughlin, S. K.; Tullis, J. S.; Naichus, M. G.; De, B. Isoxazolones Useful in Treating Discuses Associated with Unwanted Cytokine Activity. 2002-US15431[2002094266], 69: WO 15-5-2002, 2002: The Procter & Gamble Company.
9. Laughlin, S. K.; Clark, M. P.; Djung, J. F.; Golebiowski, A.; Brugel, T. A.; Sabat, M.; Bookland, R. G.; Laufersweiler, M. J.; VanRens, J. C.; Townes, J. A.; De, B.; Hsieh, L. C.; Xu, S. C.; Walter, R. L.; Mekel, M. J.; Janusz, M. J. The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-α) production. Bioorg. Med. Chem. Lett. 2005, 15, 2399-2403.
10. Dannhardt, G.; Laufer, S.; Obergrusberger, I. A new synthesis of 3.4-diaryl-5-oxo-4,5-dihydroisoxazoles and their transformation to 5-[N-(w-aminoalkyl)amino]isoxazoles and 5-(2-aminoethylthio)isoxazoles. Synthesis 1989, 27, 5-280.
11. Elguero, J., Marzin, C., Katritzky, A. R., Linda, P., Eds. Advances in Heterocyclic Chemistry, Supplement I: The Tautomerism of Hetemcycles: Academic Press: New York, 1976; p 656.
12. Kohler, E. P.; Blatt, A. H. Diphenylisoxazolone. Study of the tautomerism of isoxazolones. J. Am. Chem. Soc. 1928, 50, 504-515.
13. Katritzky, A. R.; Barezynski, P.; Ostercamp, D. L.; Yousaf, T. I. Mechanisms of heterocyclic ring formations. 4. A carbon-13 NMR study of the reaction of b-keto esters with hvdroxylamine. J. Org. Chem. 1986, 51, 4037-4042.
14. Boulton, A. J.; Katritzky, A. R. Tautomerism of heteroaromatic compounds with five-membered rings. I. 5-Hydroxyisoxazoles-5-isoxaxolones. Tetrahedron 1961, 12, 41-50.
15. Franchini, P. F. Dipole moments and tautomerism of isoxazolin-5-ones. Corsie Semin. Chim. 1968, 14, 23-25.
16. Cencioni, R.; Franchini, P. F.; Orienti, M. Dipole moments of 5-substituted isoxazoles. 1. Dipole moments and tautomerism of isoxazolin-5-ones. Tetrahedron 1968, 24, 151-166.
17. Jacquier, R.; Petrus, C.; Petrus, F.; Verducci, J. Azoles. LXXII. Unequivocal synthesis and tautomerism of 3-isoxazolones. Bull. Soc. Chim. Fr. 1970, 197, 8-1985.
18. Frolund, B.; Jensen, L. S.; Guandalini, L.; Canillo, C.; Vestergaard, H. T.; Kristiansen, U.; Nielsen, B.; Stensbol, T. B.; Madsen, C.; Krogsgaard-Larsen, P.; Liljefors, T. Potent 4-Aryl- or 4-arylalkyl-substituted 3-isoxazolol GABAA antagonists: synthesis, pharmacology, and molecular modeling. J. Med. Chem. 2005, 48, 427-439.
19. Chan, A. W. K.; Crow, W. D.; Gosney, I. Isothiazole chemistry. X. Acylation, alkylation, and tautomerism in 3-hydroxyisothiazole. Tetrahedron 1970, 26, 2497-2506.
20. Laufer, S.; Thuma, S.; Peifer, C.: Greim, C.; Herweh, Y.; Albrecht, A.; Dehner, F. An immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive liquid-phase assays. Anal. Biochem. 2005, 344, 135-137.
21. Nobeli, I.; Price, S. L.; Lommerse, J. P. M.; Taylor, R. Hydrogen bonding properties of oxygen and nitrogen acceptors in aromatic heterocycles. J. Comput. Chem. 1997, 18, 2060-2074.
22. Boehm, H. J.; Brode, S.; Hesse, U.; Klebe, G. Oxygen and nitrogen in competitive situations: which is the hydrogen-bond acceptor? Chem.-Eur. J. 1996, 2, 1509-1513.